A. Simmons

发表

Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study.

J. Newcomer, R. Kahn, C. Correll, 2020, The American journal of psychiatry.

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder

M. Todtenkopf, L. Citrome, B. Silverman, 2021, Neuropsychiatric disease and treatment.

NDT_A_313840 2885..2904

M. Todtenkopf, L. Citrome, B. Silverman, 2021 .

Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study.

S. Potkin, B. Silverman, J. Kunovac, 2020, The Journal of clinical psychiatry.

F232. A PHASE 3 STUDY TO DETERMINE THE ANTIPSYCHOTIC EFFICACY AND SAFETY OF ALKS 3831 IN ADULT PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA

S. Potkin, B. Silverman, D. McDonnell, 2018, CNS Spectrums.

Long-term safety and durability of effect with a combination of olanzapine and samidorphan in patients with schizophrenia: results from a 1-year open-label extension study

D. McDonnell, S. Yagoda, C. Graham, 2020, CNS Spectrums.

A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension

R. Kahn, B. Silverman, D. McDonnell, 2021, Schizophrenia Research.

Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study.

L. Citrome, S. O'Malley, Mark P. Berry, 2019, Innovations in clinical neuroscience.

Olanzapine/samidorphan combination consistently mitigates weight gain across various subgroups of patients

Jonathan M. Meyer, D. McDonnell, S. Yagoda, 2022, CNS Spectrums.

Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia

P. Weiden, E. Achtyes, Patricia Marcy, 2018, BMC Psychiatry.

Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis

C. Correll, M. Todtenkopf, M. Højlund, 2023, The international journal of neuropsychopharmacology.

S226. A STUDY COMPARING WEIGHT GAIN FROM ALKS 3831 TO OLANZAPINE IN EARLY-ILLNESS YOUNG ADULTS WITH SCHIZOPHRENIFORM, SCHIZOPHRENIA, OR BIPOLAR I DISORDER

B. Silverman, D. McDonnell, C. Graham, 2018, Schizophrenia Bulletin.

P.3.d.040 A study comparing weight gain from ALKS 3831 to olanzapine in early-illness young adults with schizophrenia, schizophreniform, or bipolar I disorder

B. Silverman, C. Graham, A. Simmons, 2017, European Neuropsychopharmacology.

Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial.

A. Green, C. Correll, M. Brunette, 2020, The Journal of clinical psychiatry.